CD4 and chronic obstructive pulmonary disease: Together, these findings suggest that, independent of steroid usage, reduced relative abundance of the NR3C1+ subset of CD4 T cells in the E-COPD cohort might be a distinguishing factor that separates them from the NE-COPD and controls.